溶解性 | 25°C: DMSO |
存贮条件 | 储存温度-20°C |
产品介绍 | GSK2606414是口服活性的PERK高活性抑制剂,IC50为0.4 nM。 |
生化机理 | Description:IC50 Value: 0.4nM [1]GSK2606414 is an orally available, potent, and selective PERK inhibitor. Compound 38 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states [1]. It is implicated that PERK plays an important role in tumorigenesis and cancer cell survival.in vitro: N/Ain vivo: N/AClinical trial: N/A |
别名 | GSK 2606414;GSK-2606414;7-甲基-5-(1-((3-(三氟甲基)苯基)乙酰基)-2,3-二氢-1H-吲哚-5-基)-7H-吡咯并(2,3-d)嘧啶-4-胺;;GSK 2606414;GSK-2606414;7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
GSK2606414,PERK抑制剂
GSK2606414 (订货以英文为准)
编号:G125654
CAS号:1337531-36-8
分子式:C24H20F3N5O
分子量:451.44
产品名称 | GSK2606414 |
中文名称 | GSK2606414,PERK抑制剂 |
CAS号 | 1337531-36-8 |
分子式(M.F.) | C24H20F3N5O |
分子量(M.W.) | 451.44 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品